Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells
BRITISH JOURNAL OF PHARMACOLOGY 2005. doi: 10.1038/sj.bjp.0706434
L. Riganti, C. Matteoni, DI ANGELANTONIO Silvia, A. Nistri, A. Gaimarri, F. Sparatore, C. Canu Boido, F. Clementi, C. Gotti
submitter: SILVIA DI ANGELANTONIO